Baseline		Week 8
	PBO	Bimekizumab top 3 doses	PBO	Bimekizumab top 3 doses
Joints:
ACR20 RR [95% CI]	N/A	N/A	17% [5%, 45%],	80% [63%, 91%],
			N=12	N=30
ACR50 RR [95% CI]	N/A	N/A	8% [2%, 35%],	40% [25%, 58%],
			N=12	N=30
Mean DAS(CRP) [95% CI]	5.1 [4.6, 5.6],	5.0 [4.6, 5.4],	3.9 [3.2, 4.6],	3.1 [2.7, 3.6],
	N=11	N=30	N=11	N=29
Skin:
PASI 90 RR [95% CI]	N/A	N/A	0% [0%, 43%],	87% [62%, 96%],
			N=5	N=15
Mean PASI [SD]	17.6 [18.0],	11.1 [9.2],	14.1 [17.9],	0.2 [0.6],
	N=5	N=15	N=5	N=15